Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06546800
SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER
Sponsor: Pfizer
View on ClinicalTrials.gov
Summary
This post-marketing study is a multicenter cohort study in individuals aged 60 years or older vaccinated with Abrysvo (RSV vaccine）designed to confirm the safety in individuals aged 60 years or older under actual clinical practice in Japan.
Official title: SPECIAL INVESTIGATION FOR ABRYSVO INTRAMUSCULAR INJECTION -INVESTIGATION IN INDIVIDUALS AGED 60 YEARS OR OLDER-
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1100
Start Date
2025-05-27
Completion Date
2027-10-28
Last Updated
2026-02-04
Healthy Volunteers
Yes
Conditions
Interventions
BIOLOGICAL
RSVpreF vaccine
Injection in the muscle, 1 dose 0.5mL
Locations (1)
Pfizer
Tokyo, Japan